These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36715552)

  • 1. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
    Pongor LS; Schultz CW; Rinaldi L; Wangsa D; Redon CE; Takahashi N; Fialkoff G; Desai P; Zhang Y; Burkett S; Hermoni N; Vilk N; Gutin J; Gergely R; Zhao Y; Nichols S; Vilimas R; Sciuto L; Graham C; Caravaca JM; Turan S; Tsai-Wei S; Rajapakse VN; Kumar R; Upadhyay D; Kumar S; Kim YS; Roper N; Tran B; Hewitt SM; Kleiner DE; Aladjem MI; Friedman N; Hager GL; Pommier Y; Ried T; Thomas A
    Cancer Discov; 2023 Apr; 13(4):928-949. PubMed ID: 36715552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.
    Pal Choudhuri S; Girard L; Lim JYS; Wise JF; Freitas B; Yang D; Wong E; Hamilton S; Chien VD; Kim YJ; Gilbreath C; Zhong J; Phat S; Myers DT; Christensen CL; Mazloom-Farsibaf H; Stanzione M; Wong KK; Hung YP; Farago AF; Meador CB; Dyson NJ; Lawrence MS; Wu S; Drapkin BJ
    Cancer Discov; 2024 May; 14(5):804-827. PubMed ID: 38386926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.
    Kim H; Nguyen NP; Turner K; Wu S; Gujar AD; Luebeck J; Liu J; Deshpande V; Rajkumar U; Namburi S; Amin SB; Yi E; Menghi F; Schulte JH; Henssen AG; Chang HY; Beck CR; Mischel PS; Bafna V; Verhaak RGW
    Nat Genet; 2020 Sep; 52(9):891-897. PubMed ID: 32807987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in Cancer.
    Yi E; Gujar AD; Guthrie M; Kim H; Zhao D; Johnson KC; Amin SB; Costa ML; Yu Q; Das S; Jillette N; Clow PA; Cheng AW; Verhaak RGW
    Cancer Discov; 2022 Feb; 12(2):468-483. PubMed ID: 34819316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ecDNA hubs drive cooperative intermolecular oncogene expression.
    Hung KL; Yost KE; Xie L; Shi Q; Helmsauer K; Luebeck J; Schöpflin R; Lange JT; Chamorro González R; Weiser NE; Chen C; Valieva ME; Wong IT; Wu S; Dehkordi SR; Duffy CV; Kraft K; Tang J; Belk JA; Rose JC; Corces MR; Granja JM; Li R; Rajkumar U; Friedlein J; Bagchi A; Satpathy AT; Tjian R; Mundlos S; Bafna V; Henssen AG; Mischel PS; Liu Z; Chang HY
    Nature; 2021 Dec; 600(7890):731-736. PubMed ID: 34819668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the Role of Extrachromosomal DNA Amplifications in Medulloblastoma.
    Zhao D; Verhaak RGW
    Cancer Res; 2024 Feb; 84(4):515-516. PubMed ID: 38175761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
    Chen J; Guanizo A; Luong Q; Jayasekara WSN; Jayasinghe D; Inampudi C; Szczepny A; Garama DJ; Russell PA; Ganju V; Cain JE; Watkins DN; Gough DJ
    Oncogene; 2022 Jan; 41(1):138-145. PubMed ID: 34675406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer.
    Patel AS; Yoo S; Kong R; Sato T; Sinha A; Karam S; Bao L; Fridrikh M; Emoto K; Nudelman G; Powell CA; Beasley MB; Zhu J; Watanabe H
    Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33514539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress on the role of extrachromosomal DNA in tumor pathogenesis and evolution.
    Xing J; Ning Q; Tang D; Mo Z; Lei X; Tang S
    Clin Genet; 2021 Apr; 99(4):503-512. PubMed ID: 33314031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family matters: How MYC family oncogenes impact small cell lung cancer.
    Brägelmann J; Böhm S; Guthrie MR; Mollaoglu G; Oliver TG; Sos ML
    Cell Cycle; 2017 Aug; 16(16):1489-1498. PubMed ID: 28737478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of
    Choudhuri SP; Girard L; Lim JYS; Wise JF; Freitas B; Yang D; Wong E; Hamilton S; Chien VD; Gilbreath C; Zhong J; Phat S; Myers DT; Christensen CL; Stanzione M; Wong KK; Farago AF; Meador CB; Dyson NJ; Lawrence MS; Wu S; Drapkin BJ
    bioRxiv; 2023 Jun; ():. PubMed ID: 37425738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrachromosomal DNA amplifications in cancer.
    Yi E; Chamorro González R; Henssen AG; Verhaak RGW
    Nat Rev Genet; 2022 Dec; 23(12):760-771. PubMed ID: 35953594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study.
    Alves Rde C; Meurer RT; Roehe AV
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2021-5. PubMed ID: 25012251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolutionary dynamics of extrachromosomal DNA in human cancers.
    Lange JT; Rose JC; Chen CY; Pichugin Y; Xie L; Tang J; Hung KL; Yost KE; Shi Q; Erb ML; Rajkumar U; Wu S; Taschner-Mandl S; Bernkopf M; Swanton C; Liu Z; Huang W; Chang HY; Bafna V; Henssen AG; Werner B; Mischel PS
    Nat Genet; 2022 Oct; 54(10):1527-1533. PubMed ID: 36123406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and expression of the c-myc oncogene in human lung cancer cell lines.
    Little CD; Nau MM; Carney DN; Gazdar AF; Minna JD
    Nature; 1983 Nov 10-16; 306(5939):194-6. PubMed ID: 6646201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
    Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
    Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CoRAL accurately resolves extrachromosomal DNA genome structures with long-read sequencing.
    Zhu K; Jones MG; Luebeck J; Bu X; Yi H; Hung KL; Wong IT; Zhang S; Mischel PS; Chang HY; Bafna V
    Genome Res; 2024 Oct; 34(9):1344-1354. PubMed ID: 38981681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human small-cell lung cancers show amplification and expression of the N-myc gene.
    Nau MM; Brooks BJ; Carney DN; Gazdar AF; Battey JF; Sausville EA; Minna JD
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1092-6. PubMed ID: 2869482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.